financetom
Business
financetom
/
Business
/
FAA opens audit into runway incursion risks at 45 busiest US airports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FAA opens audit into runway incursion risks at 45 busiest US airports
Oct 17, 2024 12:57 PM

WASHINGTON, Oct 15 (Reuters) - The Federal Aviation

Administration said Tuesday it is opening an audit into runway

incursion risks at the 45 busiest U.S. airports after a series

of troubling near miss incidents.

Last week, the National Transportation Safety Board said

air-traffic controllers cleared an Alaska Airlines jet

last month to take off at Tennessee's Nashville International

Airport on the same runway where a Southwest Airlines ( LUV )

plane had been cleared to cross.

The runway incursion audit will include a risk profile for

each airport, along with identifying potential gaps in

procedures, equipment, and processes, and recommendations to

improve safety and is expected to be concluded in early 2025.

Over the last two years, a series of near-miss incidents have

raised concerns about U.S. aviation safety and the strain on

understaffed air-traffic-control operations. FAA Administrator

Mike Whitaker said last month the number of serious

runway-incursion incidents had fallen by over 50%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arvinas, Pfizer Report Breast Cancer Treatment Phase 3 Trial Results; Arvinas Shares Down Pre-Bell
Arvinas, Pfizer Report Breast Cancer Treatment Phase 3 Trial Results; Arvinas Shares Down Pre-Bell
Jun 2, 2025
07:21 AM EDT, 06/02/2025 (MT Newswires) -- Arvinas ( ARVN ) and Pfizer ( PFE ) on Saturday reported results from a phase 3 clinical trial of vepdegestrant monotherapy versus fulvestrant in adults with a certain type of advanced or metastatic breast cancer. Vepdegestrant showed a statistically significant and clinically meaningful improvement in progression-free survival among patients with an estrogen...
Regeneron Says Libtayo Shows Strong Results in Adjuvant Skin Cancer Trial
Regeneron Says Libtayo Shows Strong Results in Adjuvant Skin Cancer Trial
Jun 2, 2025
07:21 AM EDT, 06/02/2025 (MT Newswires) -- Regeneron (REGN) said Saturday that Libtayo reduced the risk of recurrence or death by 68% in post-surgical high-risk cutaneous squamous cell carcinoma, meeting the phase 3 C-POST trial's primary endpoint. The immunotherapy also cut the risk of locoregional and distant recurrence by 80% and 65%, respectively, the company said. Median disease-free survival was...
BioNTech, Bristol Myers Squibb to Co-Develop Bispecific Cancer Treatment
BioNTech, Bristol Myers Squibb to Co-Develop Bispecific Cancer Treatment
Jun 2, 2025
07:24 AM EDT, 06/02/2025 (MT Newswires) -- BioNTech (BNTX) and Bristol Myers Squibb ( BMY ) said Monday they have agreed to co-develop and co-commercialize BNT327, an investigational bispecific therapy across various solid tumor types. Bristol Myers Squibb ( BMY ) will make a $1.50 billion upfront payment and $2 billion in non-contingent anniversary payments through 2028, the companies said,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved